sFlt-1: a double regulator in angiogenesis-related diseases
CONCLUSION: From the summary article, sFlt-1 is a double regulator in angiogenesis-related diseases; too much or too little may cause different diseases. Therefore, maintaining the stability of sFlt-1 content in the body is essential to control the development of related diseases.PMID:34477512 | DOI:10.2174/1381612827666210902155015
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Li Liao Xingtao Zhao Mengting Zhou Ying Deng Yunxia Li Cheng Peng Source Type: research
More News: Cardiology | Cardiomyopathy | Databases & Libraries | Diabetes | Drugs & Pharmacology | Endocrinology | Heart | Hypertension | Men | Perinatology & Neonatology | Pre-eclampsia | Science